Pakistan Government To Submit New Drug Pricing Regulatory Package
This article was originally published in PharmAsia News
Pakistan's Economic Coordination Committee plans to submit legislation for a new method of pricing drugs based on current negotiations with stakeholders, including the pharmaceutical sector.
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.